1. Esfandyari S, Elkafas H, Chugh RM, Park H-S, Navarro A, Al-Hendy A. Exosomes as biomarkers for female reproductive diseases diagnosis and therapy. Int J Mol Sci. 2021;22(4):2165. [DOI:10.3390/ijms22042165]

2. Alemi F, Sadeghsoltani F, Fattah K, Hassanpour P, Malakoti F, Kardeh S, et al. Applications of engineered exosomes in drugging noncoding RNAs for cancer therapy. Chem Biol Drug. 2023;102(5):1257-75. [DOI:10.1111/cbdd.14300]

3. Izadpanah M, Yalameha B, Sani MZ, Cheragh PK, Mahdipour M, Rezabakhsh A, et al. Exosomes as theranostic agents in reproduction system. Adv Biol. 2024;8(2):2300258. [DOI:10.1002/adbi.202300258]

4. Vahidinia Z, Azami Tameh A, Barati S, Izadpanah M, Seyed Hosseini E. Nrf2 activation: a key mechanism in stem cell exosomes-mediated therapies. Cell Mol Biol Lett. 2024;29(1):30. [DOI:10.1186/s11658-024-00551-3]

5. Pegtel DM, Gould SJ. Exosomes. Annu Rev Biochem. 2019;88:487-514. [DOI:10.1146/annurev-biochem-013118-111902]

6. Chaput N, Théry C. Exosomes: immune properties and potential clinical implementations. Semin Immunopathol. 2011;33(5):419-40. [DOI:10.1007/s00281-010-0233-9]

7. Pegtel DM, van de Garde MD, Middeldorp JM. Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion. Biochim Biophys Acta Gene Regul Mech. 2011;1809(11-12):715-21. [DOI:10.1016/j.bbagrm.2011.08.002]

8. Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release. Cell Mol Life Sci. 2018;75:193-208. [DOI:10.1007/s00018-017-2595-9]

9. Negahdaripour M, Owji H, Eskandari S, Zamani M, Vakili B, Nezafat N. Small extracellular vesicles (sEVs): Discovery, functions, applications, detection methods and various engineered forms. Expert Opin Biol Ther.. 2021;21(3):371-94. [DOI:10.1080/14712598.2021.1825677]

10. Mobarak H, Heidarpour M, Lolicato F, Nouri M, Rahbarghazi R, Mahdipour M. Physiological impact of extracellular vesicles on female reproductive system; highlights to possible restorative effects on female age‐related fertility. Biofactors. 2019;45(3):293-303. [DOI:10.1002/biof.1497]

11. Hasegawa T, Konno M, Baba T, Sugeno N, Kikuchi A, Kobayashi M, et al. The AAA-ATPase VPS4 regulates extracellular secretion and lysosomal targeting of α-synuclein. PloS one. 2011;6(12):e29460. [DOI:10.1371/journal.pone.0029460]

12. Colombo M, Raposo G, Théry C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30(1):255-89. [DOI:10.1146/annurev-cellbio-101512-122326]

13. D'Souza-Schorey C, Schorey JS. Regulation and mechanisms of extracellular vesicle biogenesis and secretion. Essays Biochem. 2018;62(2):125-33. [DOI:10.1042/EBC20170078]

14. Child TJ, Tan SL. Endometriosis: aetiology, pathogenesis and treatment. Drugs. 2001;61:1735-50. [DOI:10.2165/00003495-200161120-00005]

15. Miraboutalebi SA, Dehghani Ashkezari M, Seifati SM. Endometriosis and the potential role of biomarkers in its diagnosis and treatment: A narrative review. Feyz Med Sci J. 2023;27(5):566-78. [Full text in Persian]

16. JA S. Benign and malignant endometrial implants in peritoneal cavity, and their relation to certain ovarian tumors. Surg Gynecol Obstet. 1924;38:287-311.

17. Mahmood TA, Templeton A. Prevalence and genesis of endometriosis. Hum Reprod. 1991;6(4):544-9. [DOI:10.1093/oxfordjournals.humrep.a137377]

18. Chung MS, Han SJ. Endometriosis-associated angiogenesis and anti-angiogenic therapy for endometriosis. Front Glob Womens Health. 2022;3:856316. [DOI:10.3389/fgwh.2022.856316]

19. Kim JG, Suh CS, Kim SH, Choi YM, Moon SY, Lee JY. Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP-3 protease activity in the peritoneal fluid of patients with and without endometriosis. Fertil Steril. 2000;73(5):996-1000. [DOI:10.1016/S0015-0282(00)00493-3]

20. Malvezzi H, Marengo EB, Podgaec S, Piccinato CdA. Endometriosis: current challenges in modeling a multifactorial disease of unknown etiology. J Transl Med. 2020;18:1-21. [DOI:10.1186/s12967-020-02471-0]

21. Muth DC, McAlexander MA, Ostrenga LJ, Pate NM, Izzi JM, Adams RJ, et al. Potential role of cervicovaginal extracellular particles in diagnosis of endometriosis. BMC Vet Res. 2015;11:1-6. [DOI:10.1186/s12917-015-0513-7]

22. Harp D, Driss A, Mehrabi S, Chowdhury I, Xu W, Liu D, et al. Exosomes derived from endometriotic stromal cells have enhanced angiogenic effects in vitro. Cell Tissue Res. 2016;365:187-96. [DOI:10.1007/s00441-016-2358-1]

23. Pabona JMP, Simmen FA, Nikiforov MA, Zhuang D, Shankar K, Velarde MC, et al. Krüppel-like factor 9 and progesterone receptor coregulation of decidualizing endometrial stromal cells: implications for the pathogenesis of endometriosis. J Clin Endocrinol Metab. 2012;97(3):E376-E92. [DOI:10.1210/jc.2011-2562]

24. Zhang L, Li H, Yuan M, Li D, Sun C, Wang G. Serum exosomal microRNAs as potential circulating biomarkers for endometriosis. Dis Markers. 2020;2020(1):2456340. [DOI:10.1155/2020/2456340]

25. Texidó L, Romero C, Vidal A, García-Valero J, Fernandez Montoli ME, Baixeras N, et al. Ecto‐nucleotidases activities in the contents of ovarian endometriomas: Potential biomarkers of endometriosis. Mediat Inflamm. 2014;2014(1):120673. [DOI:10.1155/2014/120673]

26. Chen J, Zhou C, Li J, Xiang X, Zhang L, Deng J, et al. miR‑21‑5p confers doxorubicin resistance in gastric cancer cells by targeting PTEN and TIMP3. Int J Mol Med. 2018;41(4):1855-66. [DOI:10.3892/ijmm.2018.3405]

27. Wu Y, Yuan W, Ding H, Wu X. Serum exosomal miRNA from endometriosis patients correlates with disease severity. Arch Gynecol Obstet. 2022:1-11. [DOI:10.1007/s00404-021-06227-z]

28. Wu J, Huang H, Huang W, Wang L, Xia X, Fang X. Analysis of exosomal lncRNA, miRNA and mRNA expression profiles and ceRNA network construction in endometriosis Epigenomics. 2020;12(14):1193-1213. [DOI:10.2217/epi-2020-0084]

29. Shan S, Yang Y, Jiang J, Yang B, Yang Y, Sun F, et al. Extracellular vesicle-derived long non-coding RNA as circulating biomarkers for endometriosis. Reprod Biomed Online. 2022;44(5):923-33. [DOI:10.1016/j.rbmo.2021.11.019]

30. Lobb RJ, Lima LG, Möller A. Exosomes: Key mediators of metastasis and pre-metastatic niche formation. Semin Cell Dev Biol. 2017;67:3-10. [DOI:10.1016/j.semcdb.2017.01.004]

31. Scheck S, Paterson ES, Henry CE. A promising future for endometriosis diagnosis and therapy: extracellular vesicles-a systematic review. Reprod Biol Endocrinol. 2022;20(1):174. [DOI:10.1186/s12958-022-01040-y]

32. Olive DL, Pritts EA. Treatment of endometriosis. N Engl J Med. 2001;345(4):266-75. [DOI:10.1056/NEJM200107263450407]

33. Barbieri RL, Evans S, Kistner RW. Danazol in the treatment of endometriosis: analysis of 100 cases with a 4-year follow-up. Fertil Steril. 1982;37(6):737-46. [DOI:10.1016/S0015-0282(16)46331-4]

34. Biberoglu K, Behrman S. Dosage aspects of danazol therapy in endometriosis: short-term and long-term effectiveness. Am J Obstet Gynecol. 1981;139(6):645-54. [DOI:10.1016/0002-9378(81)90478-6]

35. Valle RF, Sciarra JJ. Endometriosis: treatment strategies. Ann N Y Acad Sci. 2003;997(1):229-39. [DOI:10.1196/annals.1290.026]

36. de Souza Pinto LP, Ferrari G, Dos Santos IK, de Mello Roesler CR, de Mello Gindri I. Evaluation of safety and effectiveness of gestrinone in the treatment of endometriosis: a systematic review and meta-analysis. Arch Gynecol Obstet. 2023;307(1):21-37. [DOI:10.1007/s00404-022-06846-0]

37. Javadi M, Rad JS, Pashaiasl M, Farashah MSG, Roshangar L. The effects of plasma-derived extracellular vesicles on cumulus expansion and oocyte maturation in mice. Reprod Biol. 2022;22(1):100593. [DOI:10.1016/j.repbio.2021.100593]

38. Freger S, Leonardi M, Foster WG. Exosomes and their cargo are important regulators of cell function in endometriosis. Reprod Biomed Online. 2021;43(3):370-8. [DOI:10.1016/j.rbmo.2021.05.022]

39. Javadi M, Gholami Farashah MS, Roshangar L, Soleimani JR. Plasma-derived extracellular vesicles improve mice embryo development. Mol Biol Rep. 2024;51(1):621. [DOI:10.1007/s11033-024-09500-x]

40. Javadi M, Rad JS, Farashah MSG, Roshangar L. An insight on the role of altered function and expression of exosomes and microRNAs in female reproductive diseases. Reprod Sci. 2022;29(5):1395-407. [DOI:10.1007/s43032-021-00556-9]

41. Chen Z, Wang X. The role and application of exosomes and their cargos in reproductive diseases: A systematic review. Vet Sci. 2022;9(12):706. [DOI:10.3390/vetsci9120706]

42. Wu D, Lu P, Mi X, Miao J. Exosomal miR-214 from endometrial stromal cells inhibits endometriosis fibrosis. Mol Hum Reprod. 2018;24(7):357-365. [DOI:10.1093/molehr/gay019]

43. Asl FD, Sahraei SS, Kalhor N, Fazaeli H, Sheykhhasan M, Moud SS, et al. Promising effects of exosomes from menstrual blood-derived mesenchymal stem cells on endometriosis. Reprod Biol. 2023;23(3):100788. [DOI:10.1016/j.repbio.2023.100788]

44. Zhang M, Wang X, Xia X, Fang X, Zhang T, Huang F. Endometrial epithelial cells-derived exosomes deliver microRNA-30c to block the BCL9/Wnt/CD44 signaling and inhibit cell invasion and migration in ovarian endometriosis. Cell Death Discov. 2022;8(1):151. [DOI:10.1038/s41420-022-00941-6]

45. Zhang S, Wang D, Yang F, Shen Y, Li D, Deng X. Intrauterine injection of umbilical cord mesenchymal stem cell exosome gel significantly improves the pregnancy rate in thin endometrium rats. Cell Transplant. 2022;31:09636897221133345. [DOI:10.1177/09636897221133345]

46. Xin L, Lin X, Zhou F, Li C, Wang X, Yu H, et al. A scaffold laden with mesenchymal stem cell-derived exosomes for promoting endometrium regeneration and fertility restoration through macrophage immunomodulation. Acta Biomater. 2020;113:252-66. [DOI:10.1016/j.actbio.2020.06.029]